The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary ...

Robert is currently chief digital officer at the cruise line firm Viking Cruises and will join Sanofi on 15th June. His brief is to drive Sanofi’s digital, data and technology strategy ...

Sanofi said this morning that its pipeline includes ... build-up to an R&D presentation to investors that will be held in New York later today, and also after the France-headquartered group ...

NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent ...

By William K. RashbaumMichael Rothfeld and Dana Rubinstein A class-action lawsuit argues that the New York City school system falls short in helping students with emotional disabilities ...

Bank of New York Mellon ... a new stake in Sanofi in the fourth quarter valued at approximately $28,000. Larson Financial Group LLC boosted its stake in shares of Sanofi by 480.8% during the ...

I am currently accepting new clients for both individual ... from Cambridge College, Boston, MA and a Bachelor’s Degree in Psychology from Framingham State University. I have been working ...

NEW YORK (Reuters) -Sanofi's chief executive, Paul Hudson, said in an interview on Monday that the company is poised for strong growth from a variety of new drugs and is not facing imminent, costly ...